FDA approves second OTC naloxone nasal spray, Rextovy
The U.S. Food and Drug Administration has approved Rextovy, a 4 milligram naloxone hydrochloride nasal spray, for over-the-counter sale as ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
